Just diagnosed with Marchiafava-Bignami disease?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Marchiafava-Bignami disease, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Marchiafava-Bignami disease hub →Overview
Marchiafava-Bignami disease is a rare condition. Also known as MBD. Tomeko brings together the specialists, research, clinical trials, treatments and community for Marchiafava-Bignami disease so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:221074 · ICD-10 G37.1 · GARD 0006971
Find care for Marchiafava-Bignami disease
Authoritative references for Marchiafava-Bignami disease
Research & market landscape for Marchiafava-Bignami disease
Following Marchiafava-Bignami disease for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Marchiafava-Bignami disease — the real-world landscape behind the condition, in one place.
- Latest Marchiafava-Bignami disease research on PubMed ↗
- Recruiting Marchiafava-Bignami disease trials on ClinicalTrials.gov ↗
- Explore the Marchiafava-Bignami disease research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Marchiafava-Bignami disease and every rare condition. See how Tomeko works with industry →
Common questions
What is Marchiafava-Bignami disease?
Marchiafava-Bignami disease is a rare condition. Also known as MBD. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Marchiafava-Bignami disease together in one place.
What are the symptoms of Marchiafava-Bignami disease?
Symptoms of Marchiafava-Bignami disease vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Marchiafava-Bignami disease.
How is Marchiafava-Bignami disease treated?
Treatment for Marchiafava-Bignami disease depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Marchiafava-Bignami disease, and review current options with them.
What causes Marchiafava-Bignami disease — is it genetic?
The cause and inheritance of Marchiafava-Bignami disease are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Marchiafava-Bignami disease can explain what it means for you and your family.
I was just diagnosed with Marchiafava-Bignami disease — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Marchiafava-Bignami disease, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Marchiafava-Bignami disease?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Marchiafava-Bignami disease, filtered to your area.
Are there clinical trials for Marchiafava-Bignami disease?
Tomeko shows live, recruiting studies for Marchiafava-Bignami disease from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion
